The team at Helsinki Incubators is pleased to present the 8 teams selected for this year's 2-month Terkko Health X programme for early-stage teams in health & life sciences.
"This year saw 15 teams applying to take part in Terkko Health X, and once again, we were humbled by how impressive the teams as well as the ideas were. It is always delightful to see so many professionals in the field, from experienced medical doctors and researchers to ambitious university students come to us with ideas they believe can truly benefit all of society," explained a glowing Liina Laukkanen, the Project Lead for Terkko Health X. "Yet as with every year, after a rigorous interview and selection process, we made the difficult decision of picking 8 teams for this year's programme. We are grateful to all those who applied, and encourage all applicants who didn't get in to keep working hard on their ideas. Your opportunity will come!"
The 8 teams gathered at the Terkko Health Hub on Saturday the 24th & Sunday the 25th of September for a kick-off weekend during which the teams got to know each other and presented their initial ideas to their peers, after which participants went to work on the first steps of developing their ideas.
With the help of the Helsinki Think Company's COO Ifeoma Kulmala, teams worked hard on defining the problem they are tackling, outlining its causes, its sufferers, and so on, as well as defining their solution and how it would address the problem and benefit those currently affected by it.
"The teams are enthusiastic, and are showing a real commitment to developing something meaningful," said Kulmala. "It's always a pleasure to attend a pre-incubator programme and see such a dedicated group of people, and it would seem like Terkko Health X's 2022 batch is as dedicated as they come."
The teams will continue to work hard on their ideas with the help and guidance from experts such as Anna-Maria Hennell, CEO & Co-founder of Disior, Pekka Kahri, Digital and Innovation Services at Helsinki University Hospital, Kari Sinivuori, CEO of Uute Scientific and Terkko Health X alumnus, and others. Those interested in finding out more are invited to keep an eye out for more details about the Terkko Health X 2022 showcase taking place on November 4th, 2022.
You’ll find a summary of all the participating teams below. For more information, you can also check the programme's 2022 participant page.
There is a great lack of dental nurses in the dental care market and existing nurses are overworked. Oral examination account for a significant amount of production in the mark. During these examinations, a lot of dental nurses’ time is spent inputting patient information into systems as dentists conduct the examination and call out their observations using very simple language (letters and numbers). DentAI proposes a speech recognition solution to automate this process, freeing up dental nurses for other important tasks.
E-ACTIVE sees the current landscape where individuals’ fitness and overall wellbeing are being negatively impacted by leading inactive lifestyles and seeks to remedy this situation by building a solution to help those who would like to be more active but lack the motivation. By motivating its users, E-ACTIVE hopes to help them bring about meaningful change in their lives as they become more active.
Members: Nadeem Hafeez, Saima Hafeez, Hafiz Wajid Ali
Nail fungal infections (onychomycosis), widely believed to be a mere cosmetic problem, can in truth lead to discomfort, cellulitis, and, for patients with diabetes, foot ulcers. Furthermore, if diagnosis comes at too late a stage and treatment is improper, onychomycosis can even lead to the complete removal of affected nails or even entire fingers. Yet due to a combination of factors, including poor drug delivery methods to nails owing to them being made of nonvascular and largely impermeable keratin, current treatment methods for onychomycosis are often ineffective and slow acting.
Gencyst hopes to address this problem with the combined roll-out of a novel FDA approved natural active agent which has been shown to be highly effective in treating the infection and a microneedle & patch-based targeted topical delivery solution they are currently developing.
Dental caries is the world’s most prevalent, chronic, non-communicable disease. Over 2.8 billion people across the world suffer from cavities resulting from untreated caries, and it is one of the most common unmet global healthcare issues. Hammtek aims to address this issue by creating an AI-enabled hardware & software solution suitable for home use to detect caries which would analyse images and detect caries in individuals.
Members: Meng Sun, Kimi Kejia Jin
Non-communicable diseases (NCD), especially cardiovascular diseases, make up over 30% of global deaths. With NCD’s, rather than suddenly being struck by illness, patients are instead suddenly told of an illness. Levi seeks to develop combined hardware & software based solutions to monitor individuals’ well-being long-term, allowing for NCD’s to be detected and treatment to be initiated at an earlier stage than presently possible.
6. Multisensory stimulation system for cognitive rehabilitation
Members: Qifeng Yan, Joyce Zou, Yang Huang
Research has shown that changes in gamma wave neural oscillations (20-50 Hz) have been observed in several neurological disorders, and MIT Research published in Nature has shown that non-invasive 40 Hz light flickering and 40 Hz sounds can recruit both neuronal and glial responses to attenuate Alzheimer’s disease (AD) associated pathology. Further research conducted at Shanghai Medical University has found that certain aromatherapies can suppress AD related cognitive decline. Based on this research, the team is working on a non-pharmaceutical, non-invasive device-based method for cognitive rehabilitation therapy.
Computational biologists are a key part of many advanced research projects, who analyse data and generate reports. However, these professionals face a host of software-born issues in documenting, managing, and sharing results and/or reports interactively with collaborators and a global audience both before and after publication. RNAcloudomics hopes to facilitate these processes by leveraging cloud computing technologies to provide a secure platform where complex biological data types and reports can be interactively visualized, explored, and shared. By providing an easy way for scientists to organize, share, and visualize results, RNAcloudomics allows them to spend more time working on their own novel analyses as opposed to menial data-work.
Urisens sees the challenges in acquiring reliable data to screen elderly and disabled patients for renal function, hydration, and urine parameters. This data could help increase quality of care for these patients, but due to the difficulty of obtaining the data, it is practically never gathered. Urisens is working on creating a diaper embedded diagnostic screening tool which would facilitate the rapid and automatic gathering of data in a non-invasive manner allowing for better patient treatment.